AIDS TREATMENT NEWS - February 20, 2007
Summary: The inventor of the machine used to count T-cells, collect stem cells, and measure or collect many other rare cells was awarded the prestigious Kyoto Prize for advanced technology, at a ceremony in Japan.
Leonard Herzenberg, Ph.D., professor of genetics at Stanford University, received the Kyoto Prize, often called the Japanese version of the Nobel Prize, for developing the fluorescence-activated cell sorter (FACS), the machine that measures patients' CD4 cell counts, and many other cells for research. The same machine can physically sort rare blood cells such as stem cells into a separate compartment, where the living cells can be cultured for research or treatment. The dean of Stanford's School of Medicine called FACS "one of the most important medical devices ever developed."
Dr. Herzenberg received the prize November 10, 2006, at a ceremony in Japan. "I only wish it were possible to be shared with my wife and lifelong colleague, Leonore Herzenberg," he said. Leonore Herzenberg, Ph.D., is also professor of genetics at Stanford. The Kyoto Prize, for contributions to humanity as well as to science, is awarded to one individual in each research team.
The Herzenbergs may be familiar to readers of AIDS Treatment News for their studies of NAC (n-acetylcysteine) to restore antioxidant protection by correcting glutathione deficiency in HIV disease. NAC is also being studied in treatment of many other conditions, from bacterial meningitis to cocaine dependency.
For more information, see: http://news-service.stanford.edu/news/2006/november15/med-kyoto-111506.html, http://news-service.stanford.edu/news/2006/june14/herz-061406.html and http://siarchives.si.edu/research/videohistory_catalog9554.html
(Note: the third link is to the Smithsonian Institution, describing its collection of videotapes on the development of FACS.)
2007-02-20
ATN070203
Copyright © 2007 - by John S. James. See "Permission to Copy" at: http://www.aidsnews.org/canhelp. How to help AIDS Treatment News: http://www.aidsnews.org/canhelp.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .